Antibiotice plans production for critical medicines
Local pharma producer Antibiotice is planning a significant investment in the research, development, and production of critical medicines, with a proposed RON 376.8 million.
Local pharma producer Antibiotice is planning a significant investment in the research, development, and production of critical medicines, with a proposed RON 376.8 million.
Ceres Pharma, a Belgian pharmaceutical group, has announced the official completion of the integration process between its Romanian subsidiaries, Dacia Plant and Viva Pharma.
Novartis has over 550 employees in Romania and operates a manufacturing unit in the country.
Turnover was approximately RON 231 million in the first nine months of the year.
Opening of STADA production and supply-chain hub in Turda, Romania, strengthens European security of supply with more than 150 million packs of medicines per year.

Purcari Wineries announced a major step towards the completion of the voluntary public takeover bid by Maspex Romania.
Gas Transmission System Operators (TSOs) from Greece, Bulgaria, Romania, the Republic of Moldova, and Ukraine have signed a joint letter requesting their national energy regulators.
MOL Group has announced its financial results for Q3 2025, achieving a $503 million profit before tax, which remained flat year-on-year.
BCR has partnered with the Investment and Development Bank (BID), becoming the first financial institution to sign a portfolio guarantee convention aimed at funding SMEs.
The volume of retail trade in Romania saw a significant drop in September 2025, registering a -2.1% decrease compared to the same month in the previous year.